← Eichor
Study identifier: NCT07180537 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders

Condition: Rheumatoid Arthritis · Sjogren's Syndrome · Systemic Lupus Erythematosus  ·  Sponsor: Terry L. Wahls

PhaseNA
Planned participants400
Who can joinAll sexes, 18 Years to 100 Years
Healthy volunteersNo

About this study

The goal of this project is to critically evaluate the effectiveness of an online health program designed to improve diet and self-care in patients with rheumatological conditions, including rheumatoid arthritis (RA), Sjogren's syndrome (SS), systemic lupus erythematosus (SLE), mixed connective tissue disease (MCTD), psoriatic arthritis (PsA), anxiety disorders, depressive disorders and moderate depression. Additionally, investigators will assess the program's effectiveness, as well as the challenges and facilitators involved in using an online wellness program to reduce fatigue and enhance the quality of life in patients suffering from these conditions.

This description comes directly from the study's public registry record.

Talk to the study team

Study Coordinator  ·  319 384 5002  ·  ch-studies@uiowa.edu

Mary Ehlinger, BS  ·  319 384 5002  ·  AIM-Studies@uiowa.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Univeristy of IowaIowa City, Iowa, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07180537